August 20, 2024 IntegriChain Appoints Experienced High-Growth Finance Executive as CFO IntegriChain appoints Matt Heyman as Chief Financial Officer. Heyman brings IntegriChain more than a decade of experience in corporate finance, strategy, and M&A, predominately within public and private software businesses.
July 9, 2024 IntegriChain Acquires Federal Compliance Solutions, Creating Pharma’s Deepest Contracts & Pricing and Gross-to-Net Advisory and Outsourcing Team IntegriChain has acquired Federal Compliance Solutions (FCS), a leading Pharma advisory and managed services firm. This transaction creates the industry’s deepest team of experts in government pricing and payer/provider contracting, areas that have simultaneously become more outsourced in Pharma and the focus of significant regulatory and commercial changes. The combination builds on the technology, people, and pr
June 18, 2024 IntegriChain Acquires BridgeView Data Solutions, Creating the Pharmaceutical Industry’s Best-in-Class Commercial Data Solution IntegriChain has acquired BridgeView Data Solutions, the commercial data warehouse and data aggregation assets of BridgeView Life Sciences LLC (formerly Coeus Solutions) – together delivering best-in-class first- and third-party data aggregation, AI-assisted data exploration capabilities, field intelligence and alerting, and commercial data warehouse (CDW) offerings.
May 14, 2024 IntegriChain Expert to Speak on Best Price Stacking Impacts at Informa Pricing and Contracting USA Jeff Baab, Vice President of Advisory Services, will speak at Informa’s Pricing and Contracting USA conference. The session will focus on forecasting impacts of best price stacking. The hybrid conference runs May 21-23 in New Orleans, Louisiana.
April 9, 2024 Registration Opens for Access Insights Conference 2024 Co-Hosted by IntegriChain and Blue Fin Group Registration is open for the Access Insights Conference 2024, October 14-16 in Washington, DC, and co-hosted with Blue Fin Group. Designed for commercial, operational, and financial teams at pharma manufacturers, the conference will feature industry panels, healthcare policy and financial experts, and strategic and tactical best practices for data-driven patient access and therapy commercialization.
February 28, 2024 Longtime Gilead Commercial Executive Joins IntegriChain as Chairman of the Board IntegriChain appoints Jim Meyers, a highly experienced pharmaceutical commercialization executive, as Chairman of the Board. Meyers offers more than 35 years of industry experience, from his more than two decades at Gilead Sciences where he served as Chief Commercial Officer and EVP of Worldwide Commercial Operations to his leadership in emerging biopharma as a board member for a broad spectrum of clinical-stage companies.
January 2, 2024 IntegriChain Appoints Seasoned Executive to Lead Data Business for Pharma Distribution and Patient Access IntegriChain appoints Jeff Uccello as Senior Vice President and General Manager of Data Solutions. Uccello is a seasoned pharma data executive with more than 20 years of experience across a wide range of commercialization data and analytics and business leadership roles.
December 19, 2023 IntegriChain Announces Close of Nordic Capital Majority Investment IntegriChain announces close of Nordic Capital majority investment Investment, which will accelerate IntegriChain’s ambitious growth targets and cement its status as a leading commercialization platform for pharma manufacturers.
December 5, 2023 IntegriChain and Blue Fin Group Pharma Trade and Distribution Experts to Speak at Informa Trade & Channel Strategies IntegriChain pharmaceutical strategy expert Bill Roth, General Manager and Managing Partner, Blue Fin Group will be the keynote speaker at Informa’s Trade & Channel Strategies conference. In addition, distribution experts David Weiss, IntegriChain Vice President of Industry Solutions, and Jason Bogroff, Blue Fin Group Partner, will speak at the event.
